Core Scientific, Inc.
CORZ
$14.53
$0.402.83%
NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.39% | 175.61% | -35.69% | -1,006.45% | -8,592.18% |
| Total Depreciation and Amortization | -31.71% | -24.72% | -5.78% | 21.56% | 51.63% |
| Total Amortization of Deferred Charges | 251.18% | 162.42% | 85.37% | -- | -- |
| Total Other Non-Cash Items | 5.25% | -231.70% | 82.53% | 635.29% | 1,076.90% |
| Change in Net Operating Assets | 421.99% | 185.72% | -158.56% | -26.16% | -134.95% |
| Cash from Operations | 2,723.92% | -283.09% | -36.39% | 5.13% | -93.32% |
| Capital Expenditure | -3,768.55% | -177.24% | -146.96% | -1,036.91% | -1,234.04% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | -6,526.32% | -671.43% | 47.62% | 87.24% |
| Cash from Investing | -3,656.53% | -192.33% | -1,320.25% | -989.26% | -414.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -106.56% | 74.13% | 25.45% | -1,618.79% | -56.39% |
| Issuance of Common Stock | -0.82% | -99.52% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -109.15% | -107.72% | 3,369.23% | 1,284.58% | -52.70% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -583.59% | -410.22% | 10,014.08% | 1,322.57% | -329.93% |